[DOI] [PubMed] [Google Scholar] 21.Obesity
Direct effects GLP-1R mRNA and protein have been detected in human renal vascular smooth muscle cells of afferent and efferent arterioles, interlobular and arcuate arteries, and juxtaglomerular and proximal tubular cells [56]
In nonindustry-sponsored analyses, net costs per quality-adjusted life year have ranged from $237,000 to $483,000, 83 with low cost-effectiveness related to plateauing of weight benefits but continued high costs of treatment, as well as weight regain following any cessation of use
doi: 10.1016/S0140-6736(18)31773-2 59 AhrnBMasmiquelLKumarHSarginMKarsblJDJacobsenSHet al
Read clinical review A clinical breakdown of FDA warnings on compounded semaglutide and tirzepatide, including safety risks, compounding pharmacy standards, and what patients should know before using non-FDA-approved GLP-1 formulations